home / stock / dxr / dxr news

DXR News and Press, Daxor Corporation From 03/20/20

Stock Information
Company Name: Daxor Corporation
Stock Symbol: DXR
Market: NYSE
Website: daxor.com
Menu
DXR DXR Quote DXR Short DXR News DXR Articles DXR Message Board
Get DXR Alerts

News, Short Squeeze, Breakout and More Instantly...
DXR - Daxor's BVA-100 test used as guidance for COVID-19 treatment

Daxor (NYSEMKT: DXR ) announces the first use of its BVA-100 test to guide volume treatment in COVID-19 patients and released a clinical protocol for fluid guidance for the same. More news on: Daxor Corporation, Healthcare stocks news, Read more ...

DXR - Daxor Corporation's BVA-100® Test Used to Guide Treatment In COVID-19 Patient

New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus NEW YORK, March 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, ...

DXR - Daxor Corporation Contracted to Adapt Its Blood Volume Analyzer Technology for U.S. Air Force Needs

NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the U.S. Air Force (USAF) has awarded Daxor a contract to ...

DXR - Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market

NEW YORK, March 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced t...
DXR - New Research Further Demonstrates Clinical Superiority of Daxor Corporation's Blood Volume Analyzer (BVA-100®) in Critical Care

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new research from the University of Hawaii John A. Burns School ...

DXR - Daxor Corporation to Exhibit at the Society for Critical Care Medicine 49th Congress

New Data Scheduled for Presentation on Daxor’s BVA-100 ® NEW YORK, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today a...

DXR - Novel Study from Yale University Utilizes Daxor's Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin

NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces new data from The Yale University School of Medicine that was pres...
DXR - Daxor Corporation to Exhibit at American Heart Association's Scientific Sessions 2019

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces it will be attending the American Heart Association Scientific Ses...

DXR - Daxor to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 1:30 PM Central Time

New York, N. Y., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, announced that Michael Feldschuh, Chief Executive Officer of Daxor, will be...

DXR - Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension

NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data demonstrating the clinical utility of the BVA-100 test...
Previous 10 Next 10